Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third …

G Ndrepepa, S Cassese, E Xhepa, M Joner… - Clinical Research in …, 2023 - Springer
Background The frequency and prognostic value of coronary no-reflow (CNR) was
investigated in studies that have used an outdated reperfusion therapy in terms of stent …

Special Issue “Coronary Artery Disease Interventions”

L Herold, GG Toth, D von Lewinski - Journal of Clinical Medicine, 2024 - mdpi.com
The treatment and burden of patients with severe ischemic heart disease, whether acute or
chronic, remain some of the greatest challenges in cardiology [1]. Accordingly, this Special …

[HTML][HTML] Association of Pre-PCI Blood Pressure and No-Reflow in Patients with Acute ST-Elevation Coronary Infarction

X Li, C Yu, L Lei, X Liu, Y Chen, Y Wang, SF Qiu… - Global Heart, 2024 - ncbi.nlm.nih.gov
Background: Previous studies have established blood pressure (BP) as a pivotal factor
influencing no-reflow following primary percutaneous coronary intervention (PCI) in patients …

The Contemporary Management and Coronary Angioplasty Outcomes in Young Patients with ST-Elevation Myocardial Infarction (STEMI) age< 40 years old: The …

P Porapakkham, P Porapakkham, S Srimahachota… - 2024 - researchsquare.com
Background Cardiovascular disease (CVD) remains one of the major causes of death
around the world in which ST elevation MI (STEMI) is in the lead. Although the mortality rate …